Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Dynavax Technologies Corp shares valued at $140,000 were sold by Novack David F on Mar 24 ’25. At $14.00 per share, Novack David F sold 10,000 shares. The insider’s holdings dropped to 8,078 shares worth approximately $80295.31999999999 following the completion of this transaction.
Also, DAVID NOVACK purchased 10,000 shares, netting a total of over 140,000 in proceeds.
Before that, Novack David F had sold 14,020 shares from its account. In a trade valued at $190,392, the President & COO traded Dynavax Technologies Corp shares for $13.58 each. Upon closing the transaction, the insider’s holdings decreased to 14,020 shares, worth approximately $80295.31999999999.
As published in a research note from Goldman on February 11, 2025, Dynavax Technologies Corp [DVAX] has been rated down from a Neutral to a Sell and the price target has been revised to $12 from $15. Analysts at Goldman started covering the stock with ‘”a Neutral”‘ outlook in a report released in early February. As of September 27, 2022, JMP Securities has initiated its “Mkt outperform” rating for DVAX.
Analyzing DVAX Stock Performance
On last trading session,, Dynavax Technologies Corp [NASDAQ: DVAX] rose 0.81% to $9.94. The stock’s lowest price that day was $9.755, but it reached a high of $9.94 in the same session. During the last five days, there has been a drop of approximately -3.50%. Over the course of the year, Dynavax Technologies Corp shares have dropped approximately -12.81%. Shares of the company reached a 52-week high of $14.63 on 03/07/25 and a 52-week low of $9.22 on 05/14/25.
Support And Resistance Levels for Dynavax Technologies Corp (DVAX)
According to the 24-hour chart, there is a support level at 9.82, which, if violated, would cause prices to drop to 9.69. In the upper region, resistance lies at 10.00. The next price resistance is at 10.06. RSI (Relative Strength Index) is 46.23 on the 14-day chart, showing neutral technical sentiment.
Is Dynavax Technologies Corp subject to short interest?
Stocks of Dynavax Technologies Corp saw a sharp steep in short interest on 2025-06-13 dropping by -0.17 million shares to 15.17 million. Data from Yahoo Finance shows that the short interest on 2025-05-15 was 15.34 million shares. A decline of -1.15% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 8.99 of the overall float, the days-to-cover ratio (short ratio) decline to 8.99.
Which companies own the most shares of Dynavax Technologies Corp (DVAX)?
In terms of Dynavax Technologies Corp share price expectations, FactSet research, analysts set an average price target of 31 in the next 12 months, up nearly 214.4% from the previous closing price of $9.86. Analysts anticipate Dynavax Technologies Corp stock to reach 31 by 2025, with the lowest price target being 31. In spite of this, 3 analysts ranked Dynavax Technologies Corp stock as Buy at the end of 2025. On August 06, 2021, Goldman assigned a price target of “a Buy” to the stock and initiated coverage with a $19.
